Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma

Court Removes Injunction on Sun Pharma's LEQSELVI Launch in US

Farhat Nasim10 April 2025 6:05 PM IST

Delhi: In a major relief to Sun Pharmaceutical Industries Ltd, the U.S. Court of Appeals for the Federal Circuit has vacated a preliminary injunction...

CDSCO Tightens RTI Appeal Timelines, Division Heads to Face Penalties for Lapses

No Free Pass: CDSCO Mandates Registration, Import License for SEZ Drugs Sold in India

Farhat Nasim10 April 2025 2:54 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has issued a comprehensive circular laying down regulatory procedures for...

Indian Pharma Market Grows 8.7% in August, Records Rs 20,984 Crore Sales: PharmaTrac

Cardiac, GI Power Indian Pharma Market's 7.5% March Surge

Farhat Nasim9 April 2025 5:39 PM IST

New Delhi: The Indian Pharmaceutical Market (IPM) registered a healthy growth of 7.5% in value and 1.8% in unit volumes for the month of March 2025,...

Fake WHO, Abbott Emails Used in Over Rs 1.1 Crore Scam on Pharma Executive, 2 Nabbed

Ahmedabad-Based Troikaa Pharma Falls Victim To Rs 50 Lakh Cyber Fraud

Farhat Nasim9 April 2025 5:38 PM IST

Ahmedabad: An Ahmedabad-based pharmaceutical company has become the latest victim of a sophisticated cyber fraud involving email spoofing and forged...

Dettol Controversy: Reckitt Settles with Influencer Raj Shamani, But To Proceed Legally Against Dermatologist

Dettol vs. Dermatologist: HC Orders Influencer to Delete Disparaging Claims

Farhat Nasim8 April 2025 7:33 PM IST

New Delhi: In relief to Reckitt Benckiser (India) Limited, the Delhi High Court on Tuesday recorded an undertaking by social media influencer Raj...

Dr Reddys Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva

Dr Reddy's Slapped Rs 2,395 Cr Income Tax Notice, Pharma Giant Denies Allegations

Farhat Nasim8 April 2025 6:07 PM IST

Hyderabad: The Income Tax Department has issued a show cause notice to Dr Reddy's Laboratories Limited, proposing a tax demand exceeding Rs 2,395...

Delhi ITAT Deletes Rs 14.98 Cr Ad-Hoc Disallowance on Mankind Pharmas Travel Expenses

Mankind's KIND Brand Upheld by Delhi HC, KINDPAN Trademark Quashed

Farhat Nasim7 April 2025 5:27 PM IST

New Delhi: In a major relief to Mankind Pharma Limited, the Delhi High Court has directed the removal of the trademark KINDPAN from the Register...

No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in India

Risdiplam Price Disparity in India vs China, Pakistan: SC Issues Notice to Roche

Farhat Nasim6 April 2025 2:00 PM IST

It was submitted that why can't the Indian government negotiate with Roche to make the medicine for the rare disorder available at a cheaper rate.

Indian medical devices share increased from 10% to 30% of domestic requirements in last 5 years: DoP Secretary

India's Medical Device Exports to US Hit by 26% Reciprocal Tariff: AiMeD Raises Concerns

Farhat Nasim6 April 2025 11:15 AM IST

New Delhi: The imposition of a 26% reciprocal tariff by the United States on Indian medical device exports has raised serious concerns within the...

Gujarat Govt to Withdraw Dual Pricing Policy on Cardiac Stents, AiMeD Welcomes End to USFDA Bias

Farhat Nasim5 April 2025 4:33 PM IST

New Delhi: In a significant policy reversal, the Gujarat government has withdrawn a contentious dual pricing order for cardiac stents that offered...

Strides Pharma Science Singapore arm, Kenox Pharma partner to develop multiple nasal spray products for US

Strides Pharma Recalls Testosterone Gel In US Market

Farhat Nasim5 April 2025 1:27 PM IST

The Chestnut Ridge-based drugmaker, a part of Bengaluru-based Strides Pharma Science, is recalling the affected lot due to the 'Presence of Benzene'.

AbbVie to Launch Ovarian Cancer Drug ELAHERE in UK at US Price Levels

AbbVie Lowers 2025 Earnings Forecast After USD 20 Billion Acquisition Spree

Farhat Nasim5 April 2025 11:15 AM IST

AbbVie has been focusing on expanding its pipeline since its blockbuster arthritis drug, Humira, lost patent protection in 2023.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok